{"id":11296,"date":"2025-07-27T02:01:05","date_gmt":"2025-07-27T00:01:05","guid":{"rendered":"https:\/\/valintermed.com\/?p=11296"},"modified":"2025-07-27T02:01:05","modified_gmt":"2025-07-27T00:01:05","slug":"fridrih-ataksiya","status":"publish","type":"post","link":"https:\/\/valintermed.com\/en\/medlibrary\/fridrih-ataksiya\/","title":{"rendered":"Friedrich Ataxia"},"content":{"rendered":"
<\/div>\n

Friedrich ataxia is a hereditary neurodegenerative disease characterized by progressive loss of motor coordination and sensory impairment. It most often manifests itself in childhood or adolescence, but can also occur at a later age. The main clinical symptoms are ataxic gait, dysarthria, decreased muscle tone and further deterioration of limb function. This pathology is caused by degeneration of the spinal cord and cerebellum, which leads to motor and sensory disorders. To date, it is known that Friedrich ataxia is associated with mutations in the FXN gene, which is responsible for the synthesis of the protein fragilatin, which plays an important role in mitochondrial functions. Disability of patients with this disease can significantly worsen the quality of life, which emphasizes the need for early diagnosis and an integrated approach to treatment.<\/p>\n

\n
\n

Content<\/p>\nToggle<\/span><\/path><\/svg><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n